抗感染剂市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00004201
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 241
Buy Now

抗感染药物市场预计将从2022年的13596103万美元增长到2028年的16419661万美元;预计 2022 年至 2028 年复合年增长率为 3.19%。

抗感染药物是有助于预防和治疗感染的药物,例如抗菌、抗病毒、抗真菌、和抗寄生虫药物。抗感染疗法有助于治疗轻微感染和许多严重的传染病,例如肺结核和肺炎。这些疗法彻底改变了医疗保健,因为它们丰富并延长了患有所有类型传染病的患者的生命。

战略见解

抗感染药物市场分为类型、范围、给药途径、适应症、分销渠道和地理。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。该报告提供了对市场的见解和深入分析,强调市场趋势和市场动态等参数以及全球领先市场参与者的竞争分析。

抗感染药物市场利润丰厚的地区

市场洞察

政府对研究的支持不断增加活动与临床试验和目标疾病患病率上升推动抗感染药物市场

临床试验行业在过去 10 年中取得了惊人的增长。美国食品药品监督管理局 (FDA) 于 2019 年 8 月透露,已在未来 4 年内向 12 项新的临床试验研究拨款,金额超过 1500 万美元,以改善针对罕见疾病患者的医疗产品的开发。这些资助被授予来自美国各地工业界和学术界的主要研究人员。 FDA 通过孤儿产品临床试验资助计划提供资助,该计划将资金用于促进治疗罕见疾病的医用食品、生物制剂、药物和医疗器械的临床开发。赠款旨在极大地促进治疗罕见疾病的产品的上市批准,并为开发此类产品提供必要的数据。对于可能改变罕见疾病患者生活的治疗的临床试验,FDA 35 年来一直提供急需的财政支持。此外,孤儿产品临床试验资助计划的捐款支持了研究,这些研究将导致罕见疾病治疗在未来几年获得上市批准。

由于越来越多的参与者关注,COVID-19 疫苗正在显着发展。临床试验和合作以实现快速增长和充足的产能。此外,英国政府已承诺向研究人员提供 9990 万美元(8400 万英镑)的资金和制造支持,以开展 COVID-19 疫苗计划。

一些进展示例促进抗感染药物市场增长的因素如下:

  • 2022年10月,默克扩大了其位于弗吉尼亚州埃尔克顿的疫苗生产设施。
  • 2022年6月,默沙东用于预防婴儿和儿童侵袭性肺炎球菌疾病的 VAXNEUVANCE 药物获得美国 FDA 批准。
  • 2022 年 5 月,集团销售额增长 11%(以瑞士法郎计算为 10%),达到 171.2 亿美元。今年第一季度。这将鼓励公司进行更好的投资和扩张。
  • 2022 年 2 月,罗氏宣布将 COVID-19 PCR 产品组合扩展到 cobas 5800 系统,这是一种最近推出的分子实验室仪器,在接受CE 标志。其中包括 cobas SARS-CoV-2 定性分析和 cobas SARS-CoV-2 及相关分析。流感 A/B 检测。
  • 2022 年 5 月,FDA 取消了对吉利德科学研究性新药申请 (IND) 的临床搁置,该申请旨在评估注射用来那卡韦用于 HIV 治疗和 HIV 暴露前预防 (PrEP) )。
  • 2022 年 4 月,FDA 批准了吉利德科学公司 Veklury(瑞德西韦)的补充新药申请,用于治疗 12 岁以下患有 COVID-19 的儿科患者。
  • 2022 年 4 月,诺华旗下 Sandoz 宣布延长与 Ares Genetics (Ares) 的合作协议,旨在推动全球抗击抗菌素耐药性 (AMR) 的前沿数字解决方案。
  • 2022 年 4 月,诺华宣布引入新的组织结构和运营模式,旨在支持公司在未来十年作为一家专注于医药公司的创新、增长和生产力目标。

产品洞察

根据类型,抗感染药物市场分为抗菌、抗病毒、抗真菌等。预计到 2022 年,抗病毒细分市场将占据最大的市场份额。然而,预计抗真菌细分市场在预测期内的复合年增长率最高。抗真菌剂是一种选择性消除宿主体内真菌病原体且对宿主毒性较低的药物。抗真菌药物有多种形式,包括抗代谢抗真菌药物、烯丙胺和吗啉抗真菌药物、多烯抗真菌药物和唑类抗真菌药物。全身和浅表感染,如皮肤、眼睛、口腔和阴道感染,都可能由真菌引起。香港脚、癣和真菌性脑膜炎是通常使用具有杀真菌活性的抗真菌剂治疗的几种疾病。此外,预计越来越多的传染病患者和医院获得性或院内感染患者将推动市场增长。据美国疾病控制与预防中心称,每年约有 46,000 例侵袭性念珠菌病新病例出现,这是美国常见的血流感染。此外,根据 2019 年国家生物技术中心 (NCBI) 发表的一篇文章,估计每年记录约 100 万例隐球菌病病例,导致全球 625,000 人死亡。因此,传染病病例的增加正在推动抗感染药物市场的增长。

抗感染药物市场,按类型划分 - 2022年和2028年

范围洞察

根据范围,抗感染药物市场分为窄谱和广谱。窄谱细分市场预计将在 2022 年占据更大的市场份额。然而,预计广谱细分市场在预测期内将实现更高的复合年增长率。窄谱抗生素仅对有限范围的生物体有效。此外,治疗的进步可能会在未来几年开发出更先进的药物。当识别出病原体后,就会使用窄谱抗生素来治疗特定感染,因为它们不会像广谱抗生素那样破坏那么多的正常微生物。因此,导致重复感染的可能性较小。这会降低细菌耐药性,因为它们只影响某些类型的细菌,例如阿奇霉素(属于氮杂内酯亚类的大环内酯类抗生素)和克拉霉素。一些全球参与者拥有完善的研发中心,更加注重窄谱药物的开发,以避免多重耐药微生物的出现。

抗感染药物 –市场细分

抗感染药物市场按类型、范围、给药途径、适应症、分销渠道和地理位置进行细分。根据类型,市场分为抗病毒、抗菌、抗真菌等。根据范围,抗感染药物市场分为窄谱和广谱。根据给药途径,抗感染药物市场分为静脉注射、口服、外用等。根据适应症,抗感染药物市场分为艾滋病毒、结核病、呼吸道感染、肺炎等。根据分销渠道,抗感染制剂市场分为医院药店、零售药店、专科药店、电子商务等。按地域划分,抗感染药物市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本) 、印度、澳大利亚、韩国和亚太地区其他地区)、中东和美国非洲(阿联酋、沙特阿拉伯、非洲以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)。

公司简介

雅培;艾尔建公司;安斯泰来制药公司;默克公司有限公司;拜耳公司;百时美施贵宝公司;勃林格殷格翰国际有限公司; F.霍夫曼-拉罗什有限公司;吉利德科学公司;葛兰素史克公司;和诺华公司是全球抗感染药物市场的领先公司。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the anti-infective agents market?

Anti-infectives are medications that help in preventing and treating infections, these include antibacterial, antivirals, antifungals and antiparasitic medications. Anti-infective therapies help in treating minor infections as well as many serious infectious diseases tuberculosis or pneumonia. These therapies have revolutionized healthcare as they enrich and extend life of patents suffering from all types of infectious diseases

What are the driving factors for the anti-infective agents market across the country?

Factors such as the rising prevalence of targeted diseases and rising government support for research activities and clinical trials.

What are the restraining factors for the anti-infective agents market across the country?

Emergence of anti-infective drugs resistance and side effects associated with anti-infective drugs is expected to restrict the market growth during the forecast period

Who are the major players in market the anti-infective agents market?

The anti-infective agents market majorly consists of the players such as Abbott Laboratories, Inc., Allergan Plc., Astellas Pharma Inc., Merck and Co., Inc., Bayer AG, Bristol-Myers Squibb Co., Boehringer Ingelheim, F. Hoffman-La Roche Ltd., Gilead Sciences, Glaxosmithkline Plc, and Novartis AG.

Which segment is dominating the anti-infective agents market?

The global anti-infective agents market based on type, is segmented into anti-viral, anti-bacterial, anti-fungal, and anti-parasitic drug. In 2022, anti-viral segment held largest market share and the segment is estimated to grow at the fastest CAGR during the forecast period.

Which region is dominating the anti-infective agents market?

The global anti-infective agents market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2022, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR during the forecast period

The List of Companies - Anti-Infective Agents Market

  1. Abbott
  2. Allergan Plc.
  3. Astellas Pharma Inc.
  4. Merck & Co., Inc.
  5. Bayer AG
  6. Bristol-Myers Squibb Company
  7. Boehringer Ingelheim International GmbH
  8. F. Hoffmann-La Roche Ltd.
  9. Gilead Sciences, Inc.
  10. GlaxoSmithKline plc.
  11. Novartis AG

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports